RhinAer -A Comprehensive, Non-Invasive Solution for Chronic Rhinitis
For many patients struggling with chronic rhinitis, medical management does not provide the long-lasting relief they seek, and they remain tied to tissues and sprays to cope with their daily symptoms.
Approach
The RhinAer Advantage
- Disrupts posterior nasal nerve (PNN) that triggers rhinitis
- May be used to treat full length of inferior turbinate
- Incisionless and can be done under local anesthesia
- Patients are typically able to return to normal activities the same day
Clinically Proven
Demonstrated Lasting Results and High Patient Satisfaction
A prospective, multicenter study clinically demonstrated RhinAer produces impressive results with significant improvement shown in:2
- Both allergic and nonallergic patients
- ALL four TNSS symptoms: rhinorrhea, congestion, itching, and sneezing
- Post-nasal drip
- Chronic cough
- Improvement across all quality-of-life measures
Most current, in-office rhinitis treatments are not comprehensive solutions, and surgical options like septoplasty, turbinate reduction, or other ablative technologies have mixed patient responses and may not alleviate all symptoms.
Compact and portable, the Aerin® Console and the RhinAer Stylus fit seamlessly into any clinic, office, or hospital environment. RhinAer is a convenient and efficient treatment option to integrate into your practice.
RhinAer Treats the Causes of Chronic Rhinitis
RhinAer treats the root causes of rhinorrhea / post-nasal drip and congestion in a single session.
- Disrupts posterior nasal nerve (PNN) that triggers rhinitis
- May be used to treat full length of inferior turbinate to address congestion
The RhinAer stylus employs proprietary, temperature-controlled radiofrequency (RF) technology optimized for the nasal airway. Once the stylus is activated, the Aerin System automatically maintains the tip’s target temperature for therapeutic benefit while sparing surrounding tissue, including mucosa.
Patients undergoing the treatment experience minimal discomfort and recovery time.* In a recent study with the Aerin Console, there was no aerosol generation above background levels, thereby enhancing safety for physicians and staff.
- Patients with moderate to severe chronic rhinorrhea, post-nasal drip, congestion, and/or chronic clearing of the throat
- Allergy immunotherapy patients with continued drainage
- Non-allergic chronic rhinitis patients
- Post-FESS patients with uncontrolled rhinitis